397 related articles for article (PubMed ID: 31505647)
1. Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016.
Denisuik AJ; Karlowsky JA; Adam HJ; Baxter MR; Lagacé-Wiens PRS; Mulvey MR; Hoban DJ; Zhanel GG;
J Antimicrob Chemother; 2019 Aug; 74(Suppl 4):iv64-iv71. PubMed ID: 31505647
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
[TBL] [Abstract][Full Text] [Related]
3. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
4.
Stewart AG; Cottrell K; Henderson A; Vemuri K; Bauer MJ; Paterson DL; Harris PNA
Microbiol Spectr; 2021 Sep; 9(1):e0022621. PubMed ID: 34232101
[TBL] [Abstract][Full Text] [Related]
5. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae causing intra-abdominal infections from 9 tertiary hospitals in China.
Liao K; Chen Y; Wang M; Guo P; Yang Q; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Hu Z; Chu Y; Chen S; Cao B; Su J; Gui B; Duan Q; Zhang S; Shao H; Kong H; Xu Y
Diagn Microbiol Infect Dis; 2017 Jan; 87(1):45-48. PubMed ID: 27773544
[TBL] [Abstract][Full Text] [Related]
6. Nosocomial blood-stream infections from extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumonia from GB Pant Hospital, New Delhi.
Taneja J; Mishra B; Thakur A; Dogra V; Loomba P
J Infect Dev Ctries; 2010 Sep; 4(8):517-20. PubMed ID: 20818104
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
Kiratisin P; Apisarnthanarak A; Laesripa C; Saifon P
Antimicrob Agents Chemother; 2008 Aug; 52(8):2818-24. PubMed ID: 18505851
[TBL] [Abstract][Full Text] [Related]
8. Hospital cross-transmission of extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae.
Cholley P; Thouverez M; Gbaguidi-Haore H; Sauget M; Slekovec C; Bertrand X; Talon D; Hocquet D
Med Mal Infect; 2013 Aug; 43(8):331-6. PubMed ID: 23876202
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and antimicrobial susceptibility profiles of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichiacoli in China.
Wang Y; Zhang Q; Jin Y; Jin X; Yu J; Wang K
Braz J Microbiol; 2019 Jul; 50(3):669-675. PubMed ID: 30972583
[TBL] [Abstract][Full Text] [Related]
10. ESBL-positive Escherichia coli and Klebsiella pneumoniae isolates from across Canada: CANWARD surveillance study, 2007-18.
Karlowsky JA; Walkty A; Golden AR; Baxter MR; Denisuik AJ; McCracken M; Mulvey MR; Adam HJ; Zhanel GG
J Antimicrob Chemother; 2021 Oct; 76(11):2815-2824. PubMed ID: 34378029
[TBL] [Abstract][Full Text] [Related]
11. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea.
Ryoo NH; Kim EC; Hong SG; Park YJ; Lee K; Bae IK; Song EH; Jeong SH
J Antimicrob Chemother; 2005 Oct; 56(4):698-702. PubMed ID: 16141280
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3.
Lee SY; Park YJ; Yu JK; Jung S; Kim Y; Jeong SH; Arakawa Y
J Antimicrob Chemother; 2012 Dec; 67(12):2843-7. PubMed ID: 22893681
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital.
Kader AA; Kumar A
Ann Saudi Med; 2005; 25(3):239-42. PubMed ID: 16119526
[TBL] [Abstract][Full Text] [Related]
14. Molecular detection and epidemiology of extended-spectrum beta-lactamase genes prevalent in clinical isolates of Klebsiella pneumoniae and E coli from Trinidad and Tobago.
Akpaka PE; Legall B; Padman J
West Indian Med J; 2010 Dec; 59(6):591-6. PubMed ID: 21702229
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance and AmpC production in ESBL-producing Klebsiella pneumoniae and Klebsiella quasipneumoniae: A retrospective study in Japanese clinical isolates.
Watanabe N; Watari T; Otsuka Y; Ito M; Yamagata K; Fujioka M
PLoS One; 2024; 19(5):e0303353. PubMed ID: 38743684
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
[TBL] [Abstract][Full Text] [Related]
17. Distribution of CTX-M group I and group III β-lactamases produced by Escherichia coli and klebsiella pneumoniae in Lahore, Pakistan.
Abrar S; Vajeeha A; Ul-Ain N; Riaz S
Microb Pathog; 2017 Feb; 103():8-12. PubMed ID: 27956216
[TBL] [Abstract][Full Text] [Related]
18. Molecular characteristics of extended spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae and the prevalence of qnr in Extended spectrum beta-lactamase isolates in a tertiary care hospital in Korea.
Kim MH; Lee HJ; Park KS; Suh JT
Yonsei Med J; 2010 Sep; 51(5):768-74. PubMed ID: 20635454
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and Genotypic Characterization of ESBL-, AmpC-, and Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli Isolates.
Kazemian H; Heidari H; Ghanavati R; Ghafourian S; Yazdani F; Sadeghifard N; Valadbeigi H; Maleki A; Pakzad I
Med Princ Pract; 2019; 28(6):547-551. PubMed ID: 30995662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
